Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade
Trxade Group (MEDS) delivers annual revenue growth of 130%
Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade Platform and Trxade Prime. The top-line, however, missed the average Wall Street consensus. Meanwhile, the company posted a























